Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries.

Fernandez-Rozadilla C. et al, (2023), Nat Genet

Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries.

Fernandez-Rozadilla C. et al, (2022), Nat Genet

CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.

Saunders MP. et al, (2022), ESMO Open, 7

Trends in the Incidence and Mortality of the Most Common Cancers in Iraq (Iraqi Cancer Registry 1999-2019).

Alwan NAS. et al, (2022), Gulf J Oncolog, 1, 47 - 57

A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.

Kleppe A. et al, (2022), Lancet Oncol

The UK benefits from a truly National Health Service.

Barnes E. et al, (2022), Lancet

Cancer in sub-Saharan Africa: a Lancet Oncology Commission.

Ngwa W. et al, (2022), Lancet Oncol

The Influence of Activin on the Tumor Microenvironment in Colon Cancer Metastasis.

Wiley MB. et al, (2022), FASEB J, 36 Suppl 1

Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome.

Watts K. et al, (2022), Int J Cancer

The Essentials of Multiomics.

Marshall JL. et al, (2022), Oncologist, 27, 272 - 284

Immune modulation underpins the anti-cancer activity of HDAC inhibitors.

Blaszczak W. et al, (2021), Mol Oncol, 15, 3280 - 3298

Personalising cancer medicine with prognostic markers.

Kerr DJ. and Yang L., (2021), EBioMedicine, 72

Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer.

Jiang D. et al, (2021), EBioMedicine, 71

Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer.

Zhang N. et al, (2021), Lancet Oncol, 22, e358 - e368

A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma.

Booth SW. et al, (2021), BMC Cancer, 21

Genome-wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer.

Watts K. et al, (2021), Int J Cancer

Stromal composition predicts recurrence of early rectal cancer after local excision.

Jones HJ. et al, (2021), Histopathology

The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management.

Palles C. et al, (2021), Fam Cancer

Celecoxib for Stage III Colon Cancer.

Kerr DJ. et al, (2021), JAMA, 325, 1257 - 1258

An Evaluation of the Diagnostic Accuracy of a Panel of Variants in DPYD and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities.

Palles C. et al, (2021), Cancers (Basel), 13

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?